<DOC>
	<DOC>NCT01044342</DOC>
	<brief_summary>The purpose of this study is to determine if cognitive impairment induced by scopolamine is reversed using donepezil and/or AZD1446 as compared to placebo, as assessed by electroencephalogram (EEG) measures.</brief_summary>
	<brief_title>A Healthy Volunteer Study to Evaluate Reversibility of Induced Impairment of Cognition</brief_title>
	<detailed_description />
	<mesh_term>Donepezil</mesh_term>
	<criteria>BMI 1830 Nonsmoker for at least 4 weeks Any clinically relevant acute or chronic disease Hypersensitivity to scopolamine History of substance abuse</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Healthy Volunteers</keyword>
	<keyword>EEG</keyword>
</DOC>